136 related articles for article (PubMed ID: 2519930)
1. Prospects for the treatment of B cell tumors using idiotypic vaccination.
George AJ; Stevenson FK
Int Rev Immunol; 1989; 4(4):271-310. PubMed ID: 2519930
[TBL] [Abstract][Full Text] [Related]
2. Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor.
Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
Int Rev Immunol; 1989; 4(4):251-70. PubMed ID: 2519929
[No Abstract] [Full Text] [Related]
3. A genetic approach to idiotypic vaccination for B cell lymphoma.
Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
[TBL] [Abstract][Full Text] [Related]
4. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice.
Haimovich J; Kukulansky T; Weissman B; Hollander N
Cancer Immunol Immunother; 1999 Feb; 47(6):330-6. PubMed ID: 10203063
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants.
George AJ; McBride HM; Glennie MJ; Smith LJ; Stevenson FK
Hybridoma; 1991 Apr; 10(2):219-27. PubMed ID: 1908435
[TBL] [Abstract][Full Text] [Related]
6. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
7. Anti-idiotypic therapy of leukemias and lymphomas.
Stevenson FK; George AJ; Glennie MJ
Chem Immunol; 1990; 48():126-66. PubMed ID: 2403803
[TBL] [Abstract][Full Text] [Related]
8. Idiotypic responses induced by tumor: an autocrine network.
Köhler H; Raychaudhuri S; Chen JJ; Saeki Y
Int Rev Immunol; 1989; 4(4):311-20. PubMed ID: 2535274
[No Abstract] [Full Text] [Related]
9. Idiotypic vaccination against B-cell lymphoma leads to dormant tumour.
Dyke RJ; McBride H; George AJ; Hamblin TJ; Stevenson FK
Cell Immunol; 1991 Jan; 132(1):70-83. PubMed ID: 2065360
[TBL] [Abstract][Full Text] [Related]
10. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic clonotypic vaccines.
Schwartz RS
N Engl J Med; 1992 Oct; 327(17):1236-7. PubMed ID: 1406797
[No Abstract] [Full Text] [Related]
12. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
Kwak LW; Campbell M; Levy R
Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
[TBL] [Abstract][Full Text] [Related]
13. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.
Kwak LW; Campbell MJ; Czerwinski DK; Hart S; Miller RA; Levy R
N Engl J Med; 1992 Oct; 327(17):1209-15. PubMed ID: 1406793
[TBL] [Abstract][Full Text] [Related]
14. Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulin.
Armstrong AC; Cheadle EJ; Hawkins RE
BioDrugs; 2005; 19(5):289-97. PubMed ID: 16207070
[TBL] [Abstract][Full Text] [Related]
15. High-performance immunoaffinity chromatographic detection of immunoregulatory anti-idiotypic antibodies in cancer patients receiving immunotherapy.
Phillips TM
Clin Chem; 1988 Sep; 34(9):1689-92. PubMed ID: 3262021
[TBL] [Abstract][Full Text] [Related]
16. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
George AJ; Tutt AL; Stevenson FK
J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
[TBL] [Abstract][Full Text] [Related]
17. A genetic approach to idiotypic vaccination.
Hawkins RE; Winter G; Hamblin TJ; Stevenson FK; Russell SJ
J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):273-8. PubMed ID: 8280708
[TBL] [Abstract][Full Text] [Related]
18. Idiotypic interactions in immune responses to tumor-associated antigens.
Lee VK; Hellström KE; Nepom GT
Biochim Biophys Acta; 1986 Oct; 865(2):127-39. PubMed ID: 3533153
[No Abstract] [Full Text] [Related]
19. DNA fusion vaccines against B-cell tumors.
Zhu D; Rice J; Savelyeva N; Stevenson FK
Trends Mol Med; 2001 Dec; 7(12):566-72. PubMed ID: 11733220
[TBL] [Abstract][Full Text] [Related]
20. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
Weiner GJ; Hillstrom JR
J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
